NCT05582798View on ClinicalTrials.gov

Bronchiectasis Alpha-1 Augmentation Trial- Modulating Airway Neutrophil Function

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

August 12, 2024

Study Completion Date

August 12, 2024

Conditions
Bronchiectasis Adult
Interventions
DRUG

Alpha 1-Proteinase Inhibitor 180mg/kg

alpha1-proteinase inhibitor (human) intravenous infusion

DRUG

Alpha 1-Proteinase Inhibitor 120mg/kg

alpha1-proteinase inhibitor (human) intravenous infusion

DRUG

Sodium chloride

Sodium chloride 09.% intravenous infusion

Trial Locations (1)

Unknown

NHS Tayside, Dundee

All Listed Sponsors
lead

University of Dundee

OTHER